Pfizer leaves innovation-focused trade group

Pharmaceutical company Pfizer is dropping out of the Biotechnology Innovation Organization, an industrywide lobbying group representing around 1,000 companies, Seeking Alpha reported Dec. 6.

Advertisement

BIO lobbies governments on behalf of the biotech industry on issues such as regulation and taxation. On Dec. 5, BIO named John Crowley, the founder and executive chair of Amicus Therapeutics, as its new CEO.

Earlier this year, Pfizer’s competitors AstraZeneca and Teva Pharmaceutical left the other main industry trade group, Pharmaceutical Research and Manufacturers of America.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.